24 Aug Scientific Summits conference — Antwerp, 14 & 15 October 2022
We have the honour to invite you to the last Scientific Summits conference of this year, on Friday 14 & Saturday 15 October 2022 in the Sint Paulus Cloister, located in the majestic city of Antwerp.
LIVE MEETING
We are very happy to announce that this edition will be completely live and that we will return to the pre-COVID atmosphere of lively case-based table discussion.
TOP SPEAKERS, TOP CONTENT
We are proud to once again offer a top scientific program, with excellent Belgian and international key opinion leaders. The program combines case-based discussions and interactive overviews of important novelties in the field of urothelial, prostate and kidney cancer.
Friday 14 & Saturday 15 October 2022
Live meeting
Sint Paulus Cloister
Sint-Paulusplaats 19, 2000 Antwerp, Belgium
Program – Scientific Summits
Friday 14 October 2022
12h00-13h00
WELCOME & LUNCH
13h15-16h00
PROSTATE CANCER: OLIGOMETASTATIC DISEASE
13h15-13h45
Case discussion: Primary oligometastatic hormone-sensitive prostate cancer (HSPC)
Speaker: Dr. Kato Rans – KU Leuven
13h45-14h45
New insights in De Novo Oligometastatic HSPC
The radical approach
Speaker: Prof. Dr. Steven Joniau – UZ Leuven
Benefit of combined systemic treatments
Speaker: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent
Panel: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent / Prof. Dr. Charlien Berghen – UZ Leuven / Dr. Peter Schatteman – OLV Aalst
14h45-15h00
Case discussion: Oligoprogressive castration-refractory prostate cancer (CRPC)
Speaker: Prof. Dr. Gert De Meerleer – UZ Leuven
15h00-15h30
Systemic treatment in Oligoprogressive CRPC
Speaker: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent
15h30-16h00
New insights in Oligoprogressive CRPC
Speaker: Prof. Dr. Charlien Berghen – UZ Leuven
Panel: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent / Prof. Dr. Benedikt Engels – AZ Delta / Dr. Peter Schatteman – OLV Aalst
16h00-16h30
COFFEE BREAK
16h30-17h30
KIDNEY CANCER
16h30-17h30
Case discussions: surgery for challenging cases (5 min per case)
Speakers: Dr. Yannic Raskin – ZOL Genk / Dr. Peter Dekuyper – AZ Maria Middelares Gent / Dr. Geert De Naeyer – OLV Aalst
Case 1: Solitary kidney
Case 2: Bilateral tumor
Case 3: Centrally located tumor in patient with poor renal function
Case 4: Tumor thrombosis
Case 5: Local relapse
Panel: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent / Prof. Dr. Charlien Berghen – UZ Leuven / Prof. Dr. Steven Joniau – UZ Leuven
17h30-18h15
SATELLITE SYMPOSIUM BY ASTELLAS
Polymetastatic HSPC: case discussion
Speaker: Prof. Dr. Steven Joniau – UZ Leuven
Oligorecurrent metastatic prostate cancer: the Sparkle trial
Speaker: Prof. Dr. Gert De Meerleer – UZ Leuven
18h15-19h00
NETWORKING RECEPTION
19h00
DINNER
Saturday 15 October 2022
09h15-11h00
MUSCLE-INVASIVE BLADDER CANCER: LOCALISED DISEASE
09h15-09h30
Case discussion: Open versus robot-assisted radical cystectomy (RARC)
Speaker: Prof. Dr. Karel Decaestecker – AZ Maria Middelares Gent
09h30-10h15
RARC: the way to go?
Speaker: Prof. Dr. Nikhil Vasdev – Hertfordshire and Bedfordshire Urological Cancer Centre, UK
Still room for open approach!
Speaker: Prof. Dr. Hein Van Poppel – UZ Leuven
Panel: Prof. Dr. Karel Decaestecker – AZ Maria Middelares Gent / Prof. Dr. Steven Joniau – UZ Leuven / Dr. Lieven Goeman – AZ Delta
10h15-11h00
Case discussion (continued)
– What if ypT2a pN0?
– What if ypT3a pN1?
The need for adjuvant treatment
Speaker: Prof. Dr. Christof Vulsteke – AZ Maria Middelares Gent
Panel: Prof. Dr. Karel Decaestecker – AZ Maria Middelares Gent / Dr. Wim Demey – AZ Klina / Prof. Dr. Gert De Meerleer – UZ Leuven
11h00-11h30
COFFEE BREAK
11h30-12h30
ETHICS AND ECONOMY
Networking: what’s new on the horizon?
Speaker: Mr. Christophe Lemmens – Law firm Dewallens & partners
Panel: Dr. Filip Ameye – AZ Maria Middelares Gent / Dr. Lieven Goeman – AZ Delta Roeselare / Dr. Kato Rans – KU Leuven
12h30-13h00
MINI SYMPOSIUM BY FERRING
When to use adjuvant ADT after surgery?
Speaker: Prof. Dr. Steven Joniau – UZ Leuven
ADT and cardiovascular toxicity
Speaker: Prof. Dr. Bertrand Tombal – UCL